Caxton Associates (New York)’s Clorox CLX Stock Holding History
Bought
Maintained
Sold
| Quarter | Market Value | Status | Shares |
Shares Change % | Capital Flow | Portfolio Weight | Portfolio Position | |
|---|---|---|---|---|---|---|---|---|
|
2023
Q2 | – | Sell |
-2,359
| Closed | -$373K | – | 527 |
|
|
2023
Q1 | $373K | Buy |
+2,359
| New | +$373K | 0.06% | 307 |
|
|
2021
Q4 | – | Sell |
-2,584
| Closed | -$428K | – | 540 |
|
|
2021
Q3 | $428K | Buy |
2,584
+1,466
| +131% | +$243K | 0.05% | 213 |
|
|
2021
Q2 | $201K | Sell |
1,118
-3,243
| -74% | -$583K | 0.02% | 395 |
|
|
2021
Q1 | $841K | Buy |
+4,361
| New | +$841K | 0.08% | 70 |
|
|
2020
Q4 | – | Sell |
-2,594
| Closed | -$545K | – | 144 |
|
|
2020
Q3 | $545K | Buy |
+2,594
| New | +$545K | 0.06% | 99 |
|
|
2020
Q2 | – | Sell |
-6,944
| Closed | -$1.2M | – | 465 |
|
|
2020
Q1 | $1.2M | Buy |
+6,944
| New | +$1.2M | 0.22% | 43 |
|
|
2017
Q4 | – | Sell |
-15,000
| Closed | -$1.98M | – | 312 |
|
|
2017
Q3 | $1.98M | Buy |
+15,000
| New | +$1.98M | 0.07% | 152 |
|